Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

JSCB AVANGARD reported for 9 months of 2023 by RAS

11/10/23 AVAN

Yevgeny Serdyukov spoke about the situation on the SPB Exchange

11/10/23 SPBE

TCS Group plans to redomicile

11/10/23 T

Magnet opens second brewery in superstore

11/10/23 MGNT

Yakovlev started placement of additional share issue

11/10/23 IRKT

Novabev reported for 9 months of 2023 by IFRS

11/10/23 BELU

INARCTICA sales increased by 6%

11/10/23 AQUA

Sberbank reported for 10 months of 2023 by RAS

11/10/23 SBER

In the range of Megamarket appeared apartments

11/10/23 SBER

Rosbank wants to open a branch abroad

11/10/23 ROSB